Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.
about
Selenium for preventing cancerMolecular cancer prevention: Current status and future directionsFriend or foe? The current epidemiologic evidence on selenium and human cancer riskUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionSe Enhances MLCK Activation by Regulating Selenoprotein T (SelT) in the Gastric Smooth Muscle of RatsOngoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Health risk assessment of environmental selenium: Emerging evidence and challenges (Review)Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.Selenium and Human Health: Witnessing a Copernican Revolution?Differences in Redox Regulatory Systems in Human Lung and Liver Tumors Suggest Different Avenues for TherapyCancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.Inhibition of cancer antioxidant defense by natural compounds.The importance of screening for lung cancer.Selenium supplementation in radiotherapy patients: do we need to measure selenium levels in serum or blood regularly prior radiotherapy?The Second Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.Gene methylation biomarkers in sputum as a classifier for lung cancer risk.Cancer, Oxidative Stress, and Metastasis.Overcoming obstacles in the design of cancer anorexia/weight loss trials.Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.Serum selenium levels and the risk of progression of laryngeal cancer.Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated pro-tumorigenic interactions.MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signalingThe Epidemiology of Selenium and Human Health
P2860
Q24197798-8DF64756-D130-4182-BAF2-838E226DEA4EQ26797207-308C1626-BB42-417D-95D1-4649F3EBA5D2Q27015669-E8745AF6-8381-409F-9E27-AF5C406766ECQ28388931-ECAF5B2D-1075-426A-97C6-C8D51CAF2CE6Q28854339-5D002D79-2144-4F82-84BC-46622D4840CCQ31001228-3E3B36C9-D251-4A61-9DC4-9D1B460F7B7EQ33671643-EEB30665-30F8-4FE3-AA4F-F12158F4559CQ34421255-F6C8D820-2260-485D-A6C4-8F30DAACEC96Q34480665-FF79F4C2-1D53-40BB-9FD2-6D7F9879E7AAQ36416129-968B546E-684B-4783-9F60-956E578CB8C5Q36769227-A0ABC4DB-3BE5-4CF5-B457-3557A0679E83Q37716657-7C84863E-7FD4-4A31-B441-DBAD8374F719Q38243451-6059F169-64A8-4D19-9887-1AFFC4FECD12Q38289675-58932135-84AB-4867-A73A-18AC258363DDQ38635953-E1594C0F-2F5B-4CE3-AFA3-1956C621B2DCQ38689104-C3850176-05BF-461D-82C1-F2680C9CBC2BQ42362776-2D70D8CC-597E-43F6-A125-BFDD5706FE36Q46433308-DB437D68-3712-418E-83A3-1050701CA3F0Q47194265-200EF65C-93B9-4665-AB57-5F6CC7E2374AQ47774163-539D5668-0D46-4E6E-9CBD-E851B1EAA0E5Q48303390-50A7AAA5-5AEB-40F8-852A-ADA443A5C126Q50020648-78B77E4E-7B8C-4108-92F6-B947305F8F54Q58573308-89AC2EAD-C78E-47F7-BDAF-014B92B54426Q58800456-4B11F68D-950C-4341-B1C1-1FA78B5EA7D0
P2860
Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@ast
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@en
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@nl
type
label
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@ast
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@en
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@nl
prefLabel
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@ast
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@en
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@nl
P2093
P2860
P356
P1476
Randomized, double-blind, plac ...... l-cell lung cancer: ECOG 5597.
@en
P2093
Daniel D Karp
David H Johnson
Eric Frechette
Fadlo R Khuri
Gail Shaw Wright
Gary Goodman
Gerald Clamon
Gordon Okawara
Michael R Johnston
Randolph Marks
P2860
P304
P356
10.1200/JCO.2013.49.2173
P407
P577
2013-09-03T00:00:00Z